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Abstract: The first chemical study of the Indo-Pacific dorid nudibranch Aldisa andersoni 
resulted in the isolation of five chlorinated phenyl-pyrrolyloxazoles belonging to the 
phorbazole series. Two new molecules, 9-chloro-phorbazole D and M -methyl-phorbazole 
A, co-occurring with known phorbazoles A, B and D, have been characterized. 
Phorbazoles were found to be present mainly in the external part of the mollusc. The 
structures of the new compounds were determined by interpretation of spectroscopic data, 
mainly NMR and mass spectrometry and by comparison with the literature data. 
Evaluation of feeding-deterrence activity as well as in vitro growth inhibitory properties in 
human cancer cells was also carried out.
Keywords: Aldisa andersoni; nudibranch mollusc; structural elucidation;
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1. Introduction
Opisthobranchs are marine molluscs in which the shell is reduced or completely absent. They move 
slowly and their soft-bodies often present bright, attractive coloration, with multihued geometric 
patterns [1], However, despite slow movements, the absence of physical attributes and gaudy livery, 
opisthobranchs have few documented predators. Field observations and proper ecological assays have 
demonstrated that they protect themselves by employing a series of defensive strategies including 
chemicals [2], These compounds that play a fundamental role for their survival are usually small 
molecules derived from the diet, which can be accumulated in specialized anatomical parts of the 
animal, resulting in their unpleasant taste. In some species the presence of the de novo bio-synthesized 
defensive molecules has been clearly demonstrated [3,4], The ability of opisthobranchs to select 
bioactive molecules from nature has resulted in an extraordinary library of compounds with intriguing 
framework, which are not found in their terrestrial counterparts and possess the potential as new 
pharmaceutical entities [5],
In our ongoing studies on the chemical ecology of marine opisthobranchs, we have examined 
the chemical content of six specimens of Aldisa andersoni collected off Muttom coast, India 
(Indian Ocean). A. andersoni is a dorid nudibranch (order Nudibranchia, infraorder Anthobranchia, 
superfamily Doridoidea) only recorded from Sri Lanka coast (not far from the place of our collection). 
The animal presents an oval body, 20-30 mm in length and a series of rows of low tubercles on the 
blue dorsum. The tubercles are separated by black areas of pigment, the upper part of the skin is 
crossed by a bright yellow saddle behind the rhinophores and other yellow marks on the dorsum [6 ], 
These features appear to be indicative of aposematism (warning coloration), closely resembling the 
shape and the color pattern of unpalatable nudibranch species belonging to the genus Phyllidia, which 
are known to contain toxic isonitrile molecules [7], Previous studies on different Aldisa species from 
Pacific and Mediterranean areas resulted in the finding of unusual steroids. In particular, two 
feeding-deterrent sterols featuring cholic acid side chain have been reported from Aldisa cooperi [8 ], 
whereas an unusual 24-norchol-4-ene-3,22-dione has been isolated from Aldisa smaragdina [9], It 
seems that the source of steroids in Aldisa cooperi should be the sponge Anthoarcuata graceae but the 
animal is able to modify the inactive cholestenone into two active compounds. On the other hand, the 
absence of the steroid isolated from A. smaragdina in its prey, the sponge Phorbas fictitius, suggests 
the modification of a suitable precursor or a biosynthetic origin.
The chemistry of A. andersoni has not been studied previously. We found evidence of the presence 
of chlorinated phenyl pyrrolyloxazoles in the ether extract of the mollusc. These molecules were found 
to be mainly concentrated in the external part of the mollusc even though they were also detected 
in the internal glands. Two new molecules, 9-chloro-phorbazole D (1) and M-methyl-phorbazole A
(2), co-occurring with the known related phorbazoles A, B and D have been isolated and 
characterized from this mollusc. Phorbazoles have been reported to date only from the sponge Phorbas 
aff clathrata [10-12], The origin of these metabolites in A. andersoni could be ascribed to a diet based 
on Phorbas sponges although de novo biosynthesis could not be excluded.
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2. Results and Discussion
Six specimens of A. andersoni were caught by scuba diving off Muttom coast (South India) during 
November 2009, were immediately frozen at -20 °C and transferred to the laboratory. Unfortunately 
no plausible prey was observed in the same area. Anatomical dissection of the body of nudibranchs 
was precluded due to the small size and the following procedure was used to obtain the distinct 
extracts of external and internal parts. First, the whole animals were immersed in acetone (20 mL) and 
submitted to ultrasound vibration for a few minutes. By this procedure only the metabolites present in 
the skin (external part) were extracted. The solvent was removed and the animals were crushed by a 
pestle and again treated with acetone (20 mL x 3), to extract the digestive gland contents (internal 
part). After evaporation of acetone, the aqueous residue of both the extracts was partitioned between 
Et20  (50 mL x 4 ) and FLO. The two ether extracts were analyzed by Thin Layer Chromatography (TLC) 
developed in the solvent system (CHCI3/CH3OH, 8:2). Both exhibited similar metabolite pattern with a 
series of UV-visible spots significantly more concentrated in the external extract. This extract was then 
directly submitted to RP-HPLC purification (MeOH/H20  gradient) which resulted in the novel 
compounds 1 and 2 along with known phorbazoles A, B and D, that were identified by comparison of 
their spectroscopic data with the literature values [10] (see Experimental Section for details).
Analysis of NMR spectra of compounds 1 and 2 revealed a close structural relationship with known 
phorbazoles however indicating differences in the substitution pattern.
Compound 1 had a molecular formula Ci3HgCl2N20 2 deduced by LCMS (m/z 295 [M + H]+) and 
HRESIMS (m/z 316.9875 [M + Na]+), that showed a characteristic cluster for two chlorine atoms. The 
*H NMR spectrum of 1 exhibited only four sp2 signals at 5 6.27 (1 H, d, J=  2.8 Hz, H-3), 6.93 (2H, d, 
J=  8.7 Hz, H-13 and H-15), 6.97 (1H, d , J  = 2.8 Hz, H-2) and 7.81 (2H, d ,J =  8.7 Hz, H-12 and H-16), 
according to two separated spin systems in the disubstituted pyrrole unit (ring A) and 1,4 disubstituted 
benzene ring (ring C). This implied that the two chlorine atoms were located in both the pyrrole and
13 2oxazole rings. Consistent with this, the C NMR spectrum contained 11 sp carbon signals in the 
range of 111.8-159.6 ppm (Table 1). The 2D NMR experiments aided us to fully characterize the 
molecule. In particular, a series of HMBC experiments, recorded with ./ = 5 Hz and J  = 10 Hz, were 
crucial to attribute the quaternary carbons and to assign the structure as depicted in Figure 1. In fact, 
diagnostic correlations were observed between C-8  (5c 144.2) and H-12/H-16, and between C-6  
(5c 153.7) to H-2 indicating the connection of the oxazole ring to both 1,4-disubstituted benzene and 
pyrrole. Expected HMBC correlations were also observed between C-5, C-4 and C-3 to H-2 (Figure 2). 
Comparison of NMR data with those recorded in the same solvent for phorbazoles (see Experimental 
section) confirmed the suggested structure. Compound 1 possessed one more chlorine atom on the 
oxazole ring with respect to phorbazole D, thus it was named 9-chloro-phorbazole D.
The ESIMS analysis of compound 2 showed peaks at m/z 343 [M + H]+ with the typical cluster due 
to the presence of three chlorine atoms. The HRESIMS spectrum indicated the molecular formula 
Ci4H9Cl3N20 2 as deduced from the sodiated peak at m/z 364.9634 [M + Na]+. The NMR spectra of 2 
(Table 1) showed proton and carbon resonances very similar to those of phorbazole A (see Experimental 
Section and [10]), indicating the same substitution pattern in the heterocyclic rings. The only 
difference was in the presence of a 3H signal resonating at 5h 4.00 (5c 38.4), which was attributed to a 
methyl linked at the pyrrole nitrogen. Thus compound 2 was suggested to be M-methyl-phorbazole A.
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Significant HMBC correlations were observed between the M -Me and both C-2 (5c 125.2) and C-5 
(5c 115.3), in agreement with the depicted structure (Figure 2). Treatment of phorbazole A with Mel 
(see Experimental Section) gave a compound identical in all respects with compound 2, definitively 
confirming the structure.
Table 1. *H (400/600 MHz) and 13C (75/150 MHz) NMR data a of compounds 1 and 2 
in C D 3 O D .
Position 1 2
öc mult. 6h ( J  in Hz) ôc mult. 6h ( J  in Hz)
2 122.8, CH 6.97, d (2.8) 125.2, CH 7.10, s
3 111.8, CH 6.27, d (2.8) 114.7, C
4 111.8, C 112.4, C
5 115.8, C 115.3, C
6 153.7, C 152.3, C
8 144.2, C 144.2, C
9 116.6, C 117.9, C
11 119.4, C 119.1, C
12,16 127.7, CH 7.81, d (8.7) 127.8, CH 7.81, d (8.7)
13,15 116.5, CH 6.93, d (8.7) 116.9, CH 6.93, d (8.7)
14 159.6, C 159.8, C
M -Me 122.8, CH 38.4, CH3 4.00, s
a assignment made by H- H COSY, HSQC, and HMBC (J =  10 and 5 Hz) experiments.
Figure 1. (a) Structures of novel phorbazoles isolated from the external part of A. andersoni; 
(b) Structures of known phorbazoles co-occurring in the same extract.
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Figure 2. Key HMBC correlations for phorbazoles 1 and 2.
NH
OH OH
HMBC correlations
The presence of a very minor phorbazole compound was detected in the analyzed ethereal extract. 
This metabolite was isolated in very small amount which was insufficient for a detailed spectroscopic 
characterization. However, the *H NMR and ESIMS spectra were recorded and indicated the presence 
of a structure in which all positions in both the oxazole and pyrrole rings were substituted with 
chlorine atoms. In fact, a protonated molecular peak at m/z 363 [M + H]+ with a cluster consistent with 
the presence of four chlorine atoms was observed in the ESIMS spectrum whereas the *H NMR 
spectrum exhibited only two doublet signals due to the 4-hydroxyphenyl moiety (see Experimental 
Section). The compound could be tentatively identified as 2-chloro-phorbazole A, as depicted in 
Figure 3.
Figure 3. Plausible structure of 2-chloro-phorbazole A (3).
NH
OH
Phorbazole compounds were particularly concentrated in the most exposed external part of the 
nudibranch, suggesting their involvement in chemical defense. Selected phorbazoles were thus tested 
in the feeding deterrence assay (see Experimental Section) against the trophic generalist shrimp 
Palaemon elegans [13], Even though paucity of material prevented us from obtaining dose response 
curves for each compound, compound 1, compound 2 and phorbazole A resulted in significant feeding 
deterrence at a concentration of 1.0 mg/mL (Figure 4). This finding supports that A. andersoni, 
together with similarly colored phyllidiid nudibranchs, are members of a Müllerian mimetic circle in 
which different unpalatable species had an advantage from becoming similar to others [14], sharing 
conspicuous visual signals that predators rapidly learn to avoid.
Preceding studies have indicated that marine invertebrates produce bioactive natural products that 
may be useful for developing new drugs. [15] By exploring untapped geographical sources and/or 
novel groups of organisms one can maximize the search for new marine drugs to treat human diseases. 
Although immuno-modulatory activity on previously reported phorbazoles has been claimed by the 
authors [10], no manuscript has appeared on the subject. In this regard, the in vitro growth inhibitory 
activity of phorbazoles has been investigated on a panel of five human cancer cell lines, which 
included two cell lines displaying actual sensitivity to pro-apoptotic stimuli, i.e., the MCF-7 mammary
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adenocarcinoma [16,17] and the Hs683 oligodendroglioma [17,18] and three cell lines displaying 
various levels of resistance to pro-apoptotic stimuli, i.e., the A549 non-small-cell lung cancer [19] 
(NSCLC), the SKMEL-28 melanoma [20] and the U373 glioblastoma [17,18]. The MTT colorimetric 
assay [16,17,20] was employed to measure cell growth. The data obtained is illustrated in Table 2.
Figure 4. Palaemon elegans alimentary response. The zero concentration was defined as 
control, and significant differences in the consumption of treated vs. control pellets have 
been evaluated by one-tailed Fisher’s exact test (a = 0.05, n = 10 for each bar).
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Table 2. Determination of the IC50 (pM) in vitro growth inhibitory concentration by means 
of the MTT colorimetric assay in five human cancer cell lines.
Compounds versus Cancer Cell Lines
(IC50; pM)
1
(9-chloro-phorbazole D)
2
(AT-methyl-phorbazole A)
A549 (NSCLC) 29 34
MCF-7 (breast cancer) 18 25
SKMEL-28 (melanoma) 22 29
Hs683 (oligodendroglioma) 25 25
U373 (glioblastoma) 19 19
Mean ± SEM 22 ±2 26 ±2
The human cancer cell lines include the A549 NSCLC (DSMZ code ACC107), the MCF-7 breast 
adenocarcinoma (Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ) code ACC115, the 
SKMEL-28 melanoma (ATCC code HTB-72), the Hs683 oligodendroglioma (American Type Culture 
Collection (ATCC) code HTB-138), the U373 glioblastoma (European Collection of Cell Culture (ECACC) 
code 89081403) cell lines.
The data shows that compounds 1 and 2 display similar in vitro growth inhibitory activity in the 
five human cancer cell lines under study and that the growth inhibitory activity of these two 
compounds is not modified as whether the cancer cells display actual sensitivity (MCF-7; Hs683) as 
opposed to various levels of resistance (A549; SKMEL-28; U373) to pro-apoptotic stimuli. The 
in vitro growth inhibitory activity displayed by 1 and 2 are of the same range, or even higher, than 
those displayed by carboplatin [21] and temozolomide [22], which are the two compounds largely used 
to treat patients with aggressive cancers [23,24],
Mar. Drugs 2012, 10 1805
Computer-assisted phase contrast microscopy [25,26] (quantitative videomicroscopy) was then used 
to determine as to whether the in vitro growth inhibitory activity observed for 2 (for which sufficient 
amounts were available) was related or not to the cytostatic versus cytotoxic effects. The quantitative 
videomicroscopy analyses confirmed the in vitro growth inhibitory activity of M-methyl-phorbazole 
A (2) as initially revealed by the MTT colorimetric assay (Table 2) and as illustrated below in 
Figure 5.
The data shows that 2-related in vitro anticancer activity mainly relates to cytostatic effects in both 
human SKMEL-28 melanoma and U373 glioblastoma cells. The concentrations used to analyze the 
effects of 2 by means of quantitative videomicroscopy were those obtained by means of the MTT 
colorimetric assay, i.e., 30 pM for SKMEL-28 melanoma cells and 20 pM for U373 glioblastoma cells 
(Table 2). These MTT test-related IC50 concentrations (Table 2) also turned out to decrease by -50% 
the global growth activity in U373 glioblastoma and SKMEL-28 melanoma cells under quantitative 
videomicroscopy monitoring (Figure 5).
Figure 5. Quantitative videomicroscopy analyses of 2-induced effects on SKMEL-28 
melanoma and U373 glioblastoma cells.
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3. Experimental Section
3.1. General Experimental Procedures
Optical rotations were measured using a Jasco DIP 370 digital spectropolarimeter. IR spectra were 
measured on a Biorad FTS 155 FTIR spectrophotometer. ID- and 2D-NMR spectra were recorded on 
Bruker Avance-400 (400.13 MHz) and Bruker DRX-600 equipped with TXI CryoProbeTM in CD3OD 
and DMSO-r/r, (shifts are referenced to the solvent signal at 5 3.34 and 2.50, respectively) and 
13C NMR spectra were recorded on Bruker DPX-300 (75 MHz) and Bruker DRX-600 (150 MHz)
C o n t r o l
2
[3ÜLJLM)
G l io b la s tom a  Calls
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spectrometers (5 values are reported to CD3OD, 49.0 ppm and to DMSO-¿4 at 39.5 ppm). HRESIMS 
measurements were carried out on Micromass Q-TOF micro; HPLC Shimadzu liquid chromatograph 
LC-10AD was equipped with an UV SPD-10A wavelength detector and performed with a semipreparative 
column RP-18 (Supelco, 250 mm x 46 mm, 5 pm); TLC plates (KieselGel 60 F254) were from Merck. 
Solvents for chromatography were HPLC grade hence were used without further purification.
3.2. Sample Collection
Six specimens of Aldisa andersoni were collected in November 2009 from the Indian Ocean by 
G.V. and transferred to the laboratory. The nudibranchs (average size 25 mm) were identified by 
Dr. Juan Lucas Cervera (University of Cadiz).
3.3. Extraction and Purification
The frozen molluscs A. andersoni were treated, in order to obtain extracts of the mantle and the 
internal glands, separately. The external extract was obtained by simply soaking the whole animals in 
acetone bath (20 mL) for few minutes, whereas the internal extract was obtained by grinding the 
animal after sonication. The extracts were concentrated in vacuo and the aqueous residues were then 
fractionated between H20  and Et20  (4 x 50 mL). The Et20  portions were evaporated under reduced 
pressure to give 15 mg from the external and 62 mg from the internal parts of the nudibranchs. 
The external part extract was directly purified by C l8 reversed-phase HPLC using a Supelco 
RP-18 column (250 x 4.60 mm) with a linear gradient from MeOH/H20  70:30 to MeOH 100% in 
40 min (flow 1 mL/min) to afford in order of decreasing polarity phorbazole D ( / r  7.4 min, 0.7 mg), 
9-chloro-phorbazole D (1) (tR 11.8 min, 4.9 mg), phorbazole A (tR 19.2 min, 4.0 mg), phorbazole B 
(tR 21.0 min, 2.5 mg), M-methyl-phorbazole A (2) (tR 28.9 min, 1.1 mg), and 2-chloro-phorbazole A
(3) (tR 31.2 min, <0.5 mg).
3.4. 9-Chloro-phorbazole D (1)
Yellow powder (32.7%); UV (MeOH) W  (log s) 208 (6.90), 256 (6.80), 334 (7.01); IR (liquid 
film) Vmax 1614, 1506, 1449, 1406, 1278, 1176, 837 cnT1; *H NMR and 13C NMR CD3OD, see Table 1, 
*H NMR in DMSO-¿4: SH 7.73 (d, Vh,h = 8.4 Hz, 2 H, H-1 2  and H-16), 0H 7.07 (d, Vh,h = 2.9 Hz, 1H, 
H-2 ), SH 6.94 (d, Vh,h = 8.4 Hz, 2 H, H-13 and H-15), 0H 6.31 (d, Vh,h = 2.9 Hz, 1H, H-3); 13C NMR in 
DMSO-¿4: ôc 158.3 (C-14), 5C 151.7 (C-6 ), 5C 142.1 (C-8), 5C 126.2 (C-1 2  and C-16), 5C 122.5 (C-2 ), 
5c 122.3 (C-9), 5c 116.9 (C -ll), 5C 116.0 (C-13 and C-15), 5C 114.7 (C-5), 5C 113.2 (C-4), 5C 110.6 
(C-3). HRESIMS [M + Na]+ m/z 316.9875 (caled for Ci3H8C12N20 2, 316.9861).
3.5. S IMethyl-phorbazole A (2)
Yellow powder (7.3%); *H NMR and 13C NMR in CD3OD, see Table 1, *H NMR in DMSO-¿4: 
8h  7.71 (d, Vh,h = 8 .8  Hz, 2 H, H -1 2  and H-16), 0H 7.42 (s, H-2 ), 0H 6.94 (d, Vh,h = 8 .8  Hz, 2 H, H-13 
and H-15), SH 3.92 (s, 1-JV-Me); 13C NMR in DMSO-¿4: 8c 157.6 (C-14), 8C 151.3 (C-6 ), 8c 142.3 (C-8 ), 
8 C 126.1 (C-12 and C-16), 8c 124.2 (C-2), 8c 122.4 (C-9), Sc 116.1 (C-ll), 8c 115.7 (C-13 and C-15),
Mar. Drugs 2012, 10 1807
8c 115.3 (C-5), 8 c 111.2 (C-4), 8c 109.0 (C-3), 8c 37.5 (M-Me). HRESIMS [M + Na]+ m/z 364.9634 
(calcd for C14H9CI3N2O2, 364.9627).
3.6 . Méthylation o f Phorbazole A
An aliquot of phorbazole A (1 mg) was treated with 1 mL of Mel and Na2C0 3  (12 mg) in 500 pL of 
anhydrous acetone stirring at r.t. for 3 h. As reaction reached the completion, the acetone was removed 
under reduced pressure, and the reaction mixture was loaded into a Si02 column eluting with 
CHCfi/MeOH 8:2, to obtain 0.8 mg of a compound identical with the natural compound 2 by NMR 
and MS.
3.7. 2-Chloro-phorbazole A (3)
LCMS (m/z 363 [M + H]+); lU NMR in C D 3 O D : 0H 7.82 (d, Vh,h = 8.7 Hz, 2H, H-12 and H-16), 
8h 6.94 (d, Vh,h = 8.7 Hz, 2H, H-13 and H-15).
3.8. NMR Data o f Phorbazole A in CD3 OD
*H NMR (recorded at 600 MHz) SH 7.80 (d, Vh,h = 8.7, 2H, H-12 and H-16), SH 7.08 (s, 1H, H-2), 
SH 6.92 (d, Vh,h = 8.7, 2H, H-13 and H-15); 13C NMR Sc 159.7 (C-14, C), Sc 152.8 (C-6, C), Sc 144.6 
(C-8, C), 8C 127.8 (C-12 and C-16, CH), 5C 124.4 (C-9, C), 5C 120.2 (C-2, CH), Sc 119.1 (C-5 and 
C -ll, C), 8C 116.8 (C-13 and C-15, CH), Sc 113.9 (C-3 or C-4, C), 5C 113.6 (C-4 or C-3, C).
3.9. NMR Data o f Phorbazole B in CD3 OD
*H NMR (recorded at 600 MHz) 0H 7.51 (d, Vh,h = 8.0, 2H, H-12 and H-16), SH 7.29 (s, 1H, H-9), 
8h 6.82 (d, Vh,h = 8.0, 2H, H-13 and H-15); 13C NMR Sc 159.3 (C-14, C), Sc 152.1 (C-8, C), Sc 155.5 
(C-6, C), 8C 126.8 (C-12 and C-16, CH), Sc 121.1 (C-9, C), Sc 120.6 (C -ll, C), 5C 117.8 (C-5 and 
C-2, C), 8C 116.8 (C-13 and C-15, CH), Sc 111.9 (C-3 and C-4, C).
3.10. NMR Data o f Phorbazole D in CD3 OD
*H NMR (recorded at 600 MHz) SH 7.64 (d, Vh,h = 8.0, 2H, H-12 and H-16), SH 7.36 (s, 1H, H-9), 
SH 6.95 (d, 57hh = 2.0 Hz, 1H, H-2), 0H 6.90 (d, V  = 8.0, 2H, H-13 and H-15), 0H 6.26 (d, V pH = 2.0 Hz, 
1H, H-3); 13C NMR Sc 159.5 (C-14, C), 8c 155.2 (C-6, C), Sc 152.2 (C-8, C), 8c 126.2 (C-12 and 
C-16, CH), 8c 121.8 (C-2, CH), 5C 120.5 (C-9, CH), 5C 119.8 (C-ll, C), 5C 116.3 (C-13 and C-15, CH), 
Sc 111.1 (C-3, CH), C-4 and C-5 n.d.
3.11. Feeding-Deterrence Assay
The compounds were tested for their feeding deterrence activity against the generalist shrimp 
Palaemon elegans (Rathke, 1837). Assays were performed as described in Mollo [13], by using food 
pellets treated with compounds 1 and 2, and phorbazole A, at concentrations of 1.0 mg/mL. Each pure 
compound, dissolved with 0.5 mL of acetone to give the desired final concentration, was added to a 
mixture of lyophilized squid mantle, alginate, purified sea sand and mixed. After evaporation of the
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solvent, distilled water and a drop of red food color were added to make a final volume of 1.0 mL. The 
paste was hardened into a 0.25 M CaCh solution (two minutes) and cut into 10 mm long strips. 
Accordingly, controls were prepared with acetone only (zero concentration). Shrimps were collected 
along the coast of Pozzuoli, Italy, and habituated to the control food for a week before experiments. 
After three days of total fasting, ten randomly picked shrimps were assayed as a series of individual 
replicates for each concentration and the control (n = 10 for each series). Shrimps were placed 
individually into plastic beakers filled with seawater. A colored food strip was given to each shrimp, 
and shrimps were not re-used. Control and treatments were carried out in parallel. The presence of a 
red spot visible by transparency in the gastric mill and the stomach of the shrimps after 30 min was 
considered as an acceptance of the food, while the absence of the spot gave a rejection response. 
Statistical analysis between treatments and controls was performed using the one-tailed Fisher-Exact 
test, which is traditionally used with relatively small samples, with a = 0.05 as significant level. After 
the experiments, the shrimps were returned in field to the same location they were collected.
3.12. Determination o f  in Vitro Anticancer Activity
The histological types and origins of the five cancer cell lines that were used for the MTTcolorimetric 
assay are detailed in Table 2. The cells were cultured in RPMI (Lonza, Venders, Belgium) medium 
supplemented with 10% heat inactivated foetal calf serum (Lonza). All culture media were supplemented 
with 4 mM glutamine, 100 pg/mL gentamicin, and 200 U/mL penicillin and 200 pg/mL streptomycin 
(Lonza). The overall growth level of the human cancer cell lines was determined using a colorimetric 
MTT (3-[4,5-dimethylthiazol-2yl]-diphenyl tétrazolium bromide, Sigma, Belgium) assay as detailed 
previously [16,17,20,21], Six replicates of each experimental condition were performed.. Thus, this 
procedure enables the concentration of 1 and 2 that decreased by 50% the growth of each cell line after 
having cultured it with the compound of interest for 72 h (the IC50 index in pM) to be determined.
3.13. Computer-Assisted Phase Contrast Microscopy (Quantitative Videomicroscopy)
The direct visualization of compound-induced effects in terms of cytotoxicity versus cytostaticity in 
human SKMEL-28 melanoma and U373 glioblastoma cells was achieved as detailed in literature [25,26], 
Briefly, the quantitative videomicroscopy approach enables an image of the bottom of the seeded flask 
to be taken every four minutes over the course of a 72 h-observation period. Thus, 1080 digitized 
images are available for each experimental condition, which were run in triplicates. A global growth 
ratio (the GGR index) was calculated for 2, resulting in a value that can be directly compared to the 
MTT assay-determined IC50 value (Table 2). First, the global growth (GG) is calculated in each control 
and in each treated condition by dividing the number of cells on the last image by the number of cells 
on the first image. The GGR index was thus obtained for 2 by dividing the GG values calculated for 
treated SKMEL-28 or U373 cells by the GG values calculated for the control (the data are presented as 
mean ± SEM values). For example, a GGR value of 0.5 for 2 at a given experimental time means that 
this compound decreased by 50% (1.0 -  0.5 = 0.5) the global growth of the considered cancer cell 
population as compared to control.
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4. Conclusions
Phorbazoles belong to a family of compounds first isolated by Kashman et al. from the sponge 
Phorbas aff. clathrata [10], These metabolites have a unique structure in common consisting of a 
pyrrole, an oxazole and a phenol ring differing in the number and position of chlorine atoms. The 
dietary origin, most likely from a Phorbas sponge, of phorbazoles in A. andersoni, could be assumed 
on the basis of their presence in the digestive organs. However, no sponges of this genus were 
observed in the area of collection of the nudibranch population. Moreover, the presence of such 
chemicals particularly concentrated in the external part of the nudibranch suggested their involvement 
in chemical defense against potential predators, which has been confirmed by feeding deterrence 
assays. Finally, the in vitro cytostatic effect of selected phorbazoles in a small panel of tumor cells has 
been measured for the first time.
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